Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Disodium Gadoxetate
2. Eovist
3. Gadolinium (4s)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanoic Acid Disodium Salt
4. Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid
5. Gadolinium Ethoxybenzyl Dtpa
6. Gadoxetate Disodium
7. Gadoxetic Acid
8. Gadoxetic Acid Disodium
9. Gd-eob-dtpa
1. Eovist
2. Gadoxate
3. Gadoxate Disodium
4. Gadolinium Ethoxybenzyl-dtpa
5. Moli000482
6. Q1928394
7. 2-[[2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic Acid;gadolinium(3+)
8. Gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic Acid, Disodium S-[4-(4-ethoxybenzyl)-3,6,9-tris[(carboxy-ko)methyl]-3,6,9-triazaundecandioato)(5-)-k3n3,n6,n9,k2o1,o11]gadolinite(2-)
| Molecular Weight | 684.8 g/mol |
|---|---|
| Molecular Formula | C23H33GdN3O11+3 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 20 |
| Exact Mass | 685.13562 g/mol |
| Monoisotopic Mass | 685.13562 g/mol |
| Topological Polar Surface Area | 205 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 3 |
| Complexity | 739 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Eovist |
| PubMed Health | Gadoxetate (Injection) |
| Drug Classes | Diagnostic Agent |
| Drug Label | EOVIST (gadoxetate disodium) is a paramagnetic contrast agent for MRI. EOVIST is provided as a sterile, clear, colorless to pale yellow aqueous solution for intravenous injection.EOVIST contains the active pharmaceutical ingredient gadoxetate disodiu... |
| Active Ingredient | Gadoxetate disodium |
| Dosage Form | Solution |
| Route | Intravenous |
| Strength | 1.8143gm/10ml (181.43mg/ml); 2.72145gm/15ml (181.43mg/ml) |
| Market Status | Prescription |
| Company | Bayer Hlthcare |
| 2 of 2 | |
|---|---|
| Drug Name | Eovist |
| PubMed Health | Gadoxetate (Injection) |
| Drug Classes | Diagnostic Agent |
| Drug Label | EOVIST (gadoxetate disodium) is a paramagnetic contrast agent for MRI. EOVIST is provided as a sterile, clear, colorless to pale yellow aqueous solution for intravenous injection.EOVIST contains the active pharmaceutical ingredient gadoxetate disodiu... |
| Active Ingredient | Gadoxetate disodium |
| Dosage Form | Solution |
| Route | Intravenous |
| Strength | 1.8143gm/10ml (181.43mg/ml); 2.72145gm/15ml (181.43mg/ml) |
| Market Status | Prescription |
| Company | Bayer Hlthcare |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
API SUPPLIERS
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20414
Submission : 2007-05-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39660
Submission : 2024-04-01
Status : Active
Type : II
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404
Address of the Firm :
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404A2
Address of the Firm :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20414
Submission : 2007-05-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39660
Submission : 2024-04-01
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404A2
Address of the Firm : Plot No.40/A Sy.13,15,16,51,52 &182 J.N Pharma City Thanam village Parawada mand...
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404
Address of the Firm : Plot No.40/A Sy.13,15,16,51,52 &182 J.N Pharma City Thanam village Parawada mand...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
About the Company : Founded in 1983, ST Pharm (formerly known as Samchully Pharmaceutical) has been offering excellent custom manufacturing services of APIs and their intermediates to meet clients’ ...
About the Company : Viwit Pharmaceuticals Limited (Viwit), founded in 2006, is a fast-growing research-based pharmaceutical healthcare company dedicated to the development, manufacture and marketing o...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
CAS Number : 75-03-6
End Use API : Gadolinium Ethoxybenzyl Dtpa
About The Company : At Infinium Pharmachem Pvt. Ltd., we are well focused to Iodine chemistry & this is the only core area of ours. We are working as CRAMS, but our domain is very ...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Parenteral
Topical
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
